MENS — JYONG BIOTECH LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 17 SEC-registered investment managers reported holding MENS (JYONG BIOTECH LTD) in their latest 13F filings, with a combined reported value of $903.89K across 440.40K shares. That is +13.2% by share count (+49.40K shares) versus the previous quarter, while reported value moved +11.9%. Ownership is concentrated: the five largest holders account for 92.6% of reported value and the top ten for 98.4%.
Compared with the prior quarter, 2 opened new positions, 10 added to existing stakes, 2 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of JYONG BIOTECH LTD (MENS) include BlackRock Inc, Citadel Advisors, JANE STREET GROUP, LLC, ranked by reported 13F value among the 32 institutional holders on this page.
MENS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 17 | 440.40K | $903.89K | +13.2% |
| Q2 2026 | 20 | 556.93K | $1.15M | -0.1% |
| Q1 2026 | 18 | 468.23K | $1.01M | -29.2% |
| Q4 2025 | 20 | 731.23K | $2.89M | +282.0% |
| Q3 2025 | 9 | 118.46K | $4.66M | -64.4% |
| Q2 2025 | 2 | 93.89K | $781.18K | — |
Over the 6 quarters shown, institutional share counts increased 369% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q4 2025 (+282.0%).
Top Institutional Holders (Q3 2026) — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 284.12K | $582.45K | 0.00% | Add | |
| 73.41K | $150.49K | 0.00% | Add | |
| 21.23K | $43.52K | 0.00% | Add | |
| 15.25K | $32.74K | 0.00% | New | |
| 13.87K | $28.16K | 0.00% | Add | |
| 6.91K | $14.16K | 0.00% | Add | |
| 6.13K | $12.56K | 0.00% | Hold | |
| 5.04K | $10.22K | 0.00% | Reduce | |
| 3.88K | $7.96K | 0.00% | Add | |
| 3.49K | $7.16K | 0.00% | Add | |
| 3.10K | $6.36K | 0.00% | Add | |
| 1.70K | $3.48K | 0.00% | Add | |
| 1.29K | $2.62K | 0.00% | New | |
| 525 | $1.08K | 0.00% | Reduce | |
| 234 | $480 | 0.00% | Hold | |
| 206 | $423 | 0.00% | Hold | |
| 18 | $37 | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 260.32K | $538.86K | 0.00% | Add | |
| 68.88K | $142.59K | 0.00% | New | |
| 68.88K | $142.59K | 0.00% | Add | |
| 50.42K | $104.00K | 0.00% | Add | |
| 29.07K | $60.17K | 0.00% | New | |
| 22.90K | $47.40K | 0.00% | New | |
| 12.10K | $25.05K | 0.00% | Reduce | |
| 11.21K | $23.20K | 0.00% | New | |
| 6.11K | $12.65K | 0.00% | Reduce | |
| 5.93K | $12.28K | 0.00% | Add | |
| 5.38K | $11.83K | 0.00% | Reduce | |
| 4.05K | $8.38K | 0.00% | Reduce | |
| 3.40K | $7.04K | 0.00% | Reduce | |
| 2.71K | $5.61K | 0.00% | Add | |
| 2.50K | $5.18K | 0.00% | Reduce | |
| 1.56K | $3.23K | 0.00% | Reduce | |
| 1.07K | $2.21K | 0.00% | Reduce | |
| 234 | $484 | 0.00% | New | |
| 206 | $427 | 0.00% | Reduce | |
| 9 | $19 | 0.00% | New |
Q1 2026 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 258.76K | $556.33K | 0.00% | Reduce | |
| 64.23K | $138.10K | 0.00% | Hold | |
| 37.36K | $80.33K | 0.00% | Reduce | |
| 14.59K | $31.37K | 0.00% | Reduce | |
| 14.59K | $31.37K | 0.00% | Reduce | |
| 13.93K | $29.94K | 0.00% | New | |
| 13.17K | $28.32K | 0.00% | Add | |
| 11.70K | $25.16K | 0.00% | Add | |
| 11.77K | $25.00K | 0.00% | New | |
| 6.30K | $13.55K | 0.00% | Reduce | |
| 5.19K | $11.16K | 0.00% | Add | |
| 5.68K | $10.79K | 0.00% | Reduce | |
| 3.87K | $8.32K | 0.00% | Add | |
| 2.79K | $5.99K | 0.00% | Reduce | |
| 1.88K | $4.04K | 0.00% | Add | |
| 1.68K | $3.61K | 0.00% | Add | |
| 473 | $1.02K | 0.00% | New | |
| 266 | $1.00K | 0.00% | New |
Q4 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 260.82K | $1.03M | 0.00% | New | |
| 145.65K | $575.31K | 0.00% | Add | |
| 69.56K | $274.76K | 0.00% | New | |
| 64.38K | $254.31K | 0.00% | Add | |
| 40.26K | $159.02K | 0.00% | Add | |
| 40.26K | $159.02K | 0.00% | Add | |
| 28.11K | $111.05K | 0.00% | Add | |
| 23.18K | $91.57K | 0.00% | New | |
| 14.22K | $56.18K | 0.00% | New | |
| 12.39K | $48.94K | 0.00% | New | |
| 10.90K | $43.04K | 0.00% | New | |
| 6.05K | $23.90K | 0.00% | New | |
| 4.79K | $18.90K | 0.00% | Add | |
| 3.69K | $14.59K | 0.00% | New | |
| 3.54K | $13.98K | 0.00% | New | |
| 1.49K | $5.90K | 0.00% | New | |
| 1.30K | $5.13K | 0.00% | Reduce | |
| 420 | $1.66K | 0.00% | New | |
| 204 | $806 | 0.00% | New | |
| 14 | $55 | 0.00% | New |
Q3 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 53.84K | $2.12M | 0.00% | New | |
| 20.82K | $819.00K | 0.00% | Reduce | |
| 13.01K | $512.45K | 0.00% | New | |
| 13.01K | $512.45K | 0.00% | New | |
| 12.64K | $497.80K | 0.00% | Reduce | |
| 2.87K | $113.06K | 0.00% | New | |
| 1.70K | $66.87K | 0.00% | New | |
| 537 | $21.15K | 0.00% | New | |
| 26 | $1.02K | 0.00% | New |
Q2 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 70.97K | $591.18K | 0.00% | New | |
| 22.92K | $190.00K | 0.00% | New |
New Positions (Q3 2026)
- StoneX Group Inc. 15.25K sh · $32.74K
- JONES FINANCIAL COMPANIES LLLP 1.29K sh · $2.62K
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 68.88K sh · $142.59K
- HRT FINANCIAL LP sold 50.42K sh · $104.00K
- XTX Topco Ltd sold 29.07K sh · $60.17K
- Renaissance Technologies sold 22.90K sh · $47.40K
- State of Wyoming sold 11.21K sh · $23.20K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| BlackRock Inc | 284.12K | 260.32K | 258.76K | 260.82K | — | — |
| Geode Capital Management | 73.41K | 68.88K | 64.23K | 64.38K | 53.84K | — |
| Citigroup Inc | 21.23K | 2.50K | 2.79K | 10.90K | — | — |
| StoneX Group Inc. | 15.25K | — | — | — | — | — |
| China Universal Asset Management Co., Ltd. | 13.87K | 12.10K | 13.17K | 12.39K | — | — |
| BARCLAYS PLC | 6.91K | 5.93K | 5.19K | 3.54K | — | — |
| Morgan Stanley | 6.13K | 6.11K | 6.30K | 28.11K | 2.87K | — |
| JPMorgan Chase & Co | 5.04K | 5.38K | 5.68K | 6.05K | — | — |
| Mirae Asset Global Investments Co., Ltd. | 3.88K | 3.40K | 3.87K | 3.69K | — | — |
| Tower Research Capital LLC (TRC) | 3.49K | 1.07K | 11.70K | 4.79K | 26 | — |
| BNP PARIBAS FINANCIAL MARKETS | 3.10K | 2.71K | 1.88K | 1.30K | 1.70K | — |
| GF FUND MANAGEMENT CO. LTD. | 1.70K | 1.56K | 1.68K | 1.49K | — | — |
| JONES FINANCIAL COMPANIES LLLP | 1.29K | — | — | — | — | — |
| UBS Group AG | 525 | 4.05K | 37.36K | 145.65K | 537 | — |
| Cornerstone Financial Management LLC | 234 | 234 | — | 14 | — | — |
| Bell Investment Advisors, Inc | 206 | 206 | 473 | — | — | — |
| Caitong International Asset Management Co., Ltd | 18 | 9 | — | — | — | — |
| HRT FINANCIAL LP | — | 50.42K | 11.77K | — | 20.82K | 22.92K |
| Citadel Advisors | — | — | — | — | 12.64K | 70.97K |
| MILLENNIUM MANAGEMENT LLC | — | — | 14.59K | 40.26K | 13.01K | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold MENS?
As of 2026-Q3, 17 institutional funds reported holding MENS (JYONG BIOTECH LTD) in SEC 13F filings, with a combined reported value of $903.89K.
How many shares of MENS do institutions own?
13F filers reported 440.40K shares of MENS, worth $903.89K in aggregate at the end of 2026-Q3.
Is institutional ownership of MENS rising or falling?
Share counts moved +13.2% versus the prior quarter — accumulation.
Who are the top institutional holders of MENS?
The largest 13F holders are BlackRock Inc, Citadel Advisors, JANE STREET GROUP, LLC, Geode Capital Management, GEODE CAPITAL MANAGEMENT, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of JYONG BIOTECH LTD?
The major shareholders of JYONG BIOTECH LTD (MENS) by reported 13F value are BlackRock Inc, Citadel Advisors, JANE STREET GROUP, LLC, Geode Capital Management, GEODE CAPITAL MANAGEMENT, LLC, among 32 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.